Functions of plasmalogen lipids in health and disease

Nancy E. Braverman, Ann B. Moser

Research output: Contribution to journalArticle

Abstract

Plasmalogens are a unique class of membrane glycerophospholipids containing a fatty alcohol with a vinyl-ether bond at the sn-1 position, and enriched in polyunsaturated fatty acids at the sn-2 position of the glycerol backbone. These two features provide novel properties to these compounds. Although plasmalogens represent up to 20% of the total phospholipid mass in humans their physiological roles have been challenging to identify, and are likely to be particular to different tissues, metabolic processes and developmental stages. Their biosynthesis starts in peroxisomes, and defects at these steps cause the malformation syndrome, Rhizomelic Chondrodysplasia Punctata (RCDP). The RCDP phenotype predicts developmental roles for plasmalogens in bone, brain, lens, lung, kidney and heart. Recent studies have revealed secondary plasmalogen deficiencies associated with more common disorders and allow us to tease out additional pathways dependent on plasmalogen functions. In this review, we present current knowledge of plasmalogen biology in health and disease. This article is part of a Special Issue entitled: Metabolic Functions and Biogenesis of peroxisomes in Health and Disease.

Original languageEnglish (US)
Pages (from-to)1442-1452
Number of pages11
JournalBiochimica et Biophysica Acta - Molecular Basis of Disease
Volume1822
Issue number9
DOIs
StatePublished - Sep 2012

Fingerprint

Plasmalogens
Lipids
Rhizomelic Chondrodysplasia Punctata
Health
Peroxisomes
Fatty Alcohols
Glycerophospholipids
Unsaturated Fatty Acids
Glycerol
Lenses
Phospholipids
Phenotype
Kidney
Bone and Bones
Lung
Membranes
Brain

Keywords

  • Alzheimer disease
  • Lipid signaling
  • Plasmalogen
  • Plasmalogen replacement therapy
  • Respiratory disease
  • Rhizomelic Chondrodysplasia Punctata

ASJC Scopus subject areas

  • Molecular Biology
  • Molecular Medicine

Cite this

Functions of plasmalogen lipids in health and disease. / Braverman, Nancy E.; Moser, Ann B.

In: Biochimica et Biophysica Acta - Molecular Basis of Disease, Vol. 1822, No. 9, 09.2012, p. 1442-1452.

Research output: Contribution to journalArticle

@article{fd4ffdd54b7d48659d604b4f6d4b9ce6,
title = "Functions of plasmalogen lipids in health and disease",
abstract = "Plasmalogens are a unique class of membrane glycerophospholipids containing a fatty alcohol with a vinyl-ether bond at the sn-1 position, and enriched in polyunsaturated fatty acids at the sn-2 position of the glycerol backbone. These two features provide novel properties to these compounds. Although plasmalogens represent up to 20{\%} of the total phospholipid mass in humans their physiological roles have been challenging to identify, and are likely to be particular to different tissues, metabolic processes and developmental stages. Their biosynthesis starts in peroxisomes, and defects at these steps cause the malformation syndrome, Rhizomelic Chondrodysplasia Punctata (RCDP). The RCDP phenotype predicts developmental roles for plasmalogens in bone, brain, lens, lung, kidney and heart. Recent studies have revealed secondary plasmalogen deficiencies associated with more common disorders and allow us to tease out additional pathways dependent on plasmalogen functions. In this review, we present current knowledge of plasmalogen biology in health and disease. This article is part of a Special Issue entitled: Metabolic Functions and Biogenesis of peroxisomes in Health and Disease.",
keywords = "Alzheimer disease, Lipid signaling, Plasmalogen, Plasmalogen replacement therapy, Respiratory disease, Rhizomelic Chondrodysplasia Punctata",
author = "Braverman, {Nancy E.} and Moser, {Ann B.}",
year = "2012",
month = "9",
doi = "10.1016/j.bbadis.2012.05.008",
language = "English (US)",
volume = "1822",
pages = "1442--1452",
journal = "Biochimica et Biophysica Acta - Molecular Basis of Disease",
issn = "0925-4439",
publisher = "Elsevier",
number = "9",

}

TY - JOUR

T1 - Functions of plasmalogen lipids in health and disease

AU - Braverman, Nancy E.

AU - Moser, Ann B.

PY - 2012/9

Y1 - 2012/9

N2 - Plasmalogens are a unique class of membrane glycerophospholipids containing a fatty alcohol with a vinyl-ether bond at the sn-1 position, and enriched in polyunsaturated fatty acids at the sn-2 position of the glycerol backbone. These two features provide novel properties to these compounds. Although plasmalogens represent up to 20% of the total phospholipid mass in humans their physiological roles have been challenging to identify, and are likely to be particular to different tissues, metabolic processes and developmental stages. Their biosynthesis starts in peroxisomes, and defects at these steps cause the malformation syndrome, Rhizomelic Chondrodysplasia Punctata (RCDP). The RCDP phenotype predicts developmental roles for plasmalogens in bone, brain, lens, lung, kidney and heart. Recent studies have revealed secondary plasmalogen deficiencies associated with more common disorders and allow us to tease out additional pathways dependent on plasmalogen functions. In this review, we present current knowledge of plasmalogen biology in health and disease. This article is part of a Special Issue entitled: Metabolic Functions and Biogenesis of peroxisomes in Health and Disease.

AB - Plasmalogens are a unique class of membrane glycerophospholipids containing a fatty alcohol with a vinyl-ether bond at the sn-1 position, and enriched in polyunsaturated fatty acids at the sn-2 position of the glycerol backbone. These two features provide novel properties to these compounds. Although plasmalogens represent up to 20% of the total phospholipid mass in humans their physiological roles have been challenging to identify, and are likely to be particular to different tissues, metabolic processes and developmental stages. Their biosynthesis starts in peroxisomes, and defects at these steps cause the malformation syndrome, Rhizomelic Chondrodysplasia Punctata (RCDP). The RCDP phenotype predicts developmental roles for plasmalogens in bone, brain, lens, lung, kidney and heart. Recent studies have revealed secondary plasmalogen deficiencies associated with more common disorders and allow us to tease out additional pathways dependent on plasmalogen functions. In this review, we present current knowledge of plasmalogen biology in health and disease. This article is part of a Special Issue entitled: Metabolic Functions and Biogenesis of peroxisomes in Health and Disease.

KW - Alzheimer disease

KW - Lipid signaling

KW - Plasmalogen

KW - Plasmalogen replacement therapy

KW - Respiratory disease

KW - Rhizomelic Chondrodysplasia Punctata

UR - http://www.scopus.com/inward/record.url?scp=84864046701&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84864046701&partnerID=8YFLogxK

U2 - 10.1016/j.bbadis.2012.05.008

DO - 10.1016/j.bbadis.2012.05.008

M3 - Article

C2 - 22627108

AN - SCOPUS:84864046701

VL - 1822

SP - 1442

EP - 1452

JO - Biochimica et Biophysica Acta - Molecular Basis of Disease

JF - Biochimica et Biophysica Acta - Molecular Basis of Disease

SN - 0925-4439

IS - 9

ER -